These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 466214)

  • 1. Fetal death in utero managed with vaginal prostaglandin E2 gel.
    MacKenzie IZ; Davies AJ; Embrey MP
    Br Med J; 1979 Jun; 1(6180):1764-5. PubMed ID: 466214
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaginal prostaglandin E2 in the management of fetal intrauterine death.
    Southern EM; Gutknecht GD; Mohberg NR; Edelman DA
    Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of labour.
    Embrey MP
    Br Med J; 1979 Sep; 2(6193):793. PubMed ID: 519197
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy.
    Calder AA; Mackenzie IZ; Embrey MP
    J Reprod Med; 1976 May; 16(5):271-5. PubMed ID: 933106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new prostaglandin E1 analog in late interruption of pregnancy, in utero deaths and very premature ruptures of the membranes. Apropos of 117 cases].
    Henrion R; Oury JF; Dumez Y; Ammous A; Vige P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(8):939-46. PubMed ID: 6543368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare obstetric contraindication to the use of vaginal prostaglandins for fetal demise.
    Waszak SJ
    J Reprod Med; 1979 Apr; 22(4):204-6. PubMed ID: 458763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
    Boehm FH; Killam AP; Chambers JF; Davidson KK
    Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins.
    Bellows JG
    Compr Ther; 1978 Apr; 4(4):3-5. PubMed ID: 348390
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with prostaglandin E 2 and F 2 alpha in the termination of pregnancy and labor induction in intrauterine fetal death].
    Kunz J; Schreiner WE
    Schweiz Med Wochenschr; 1977 Jun; 107(22):757-63. PubMed ID: 877524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
    Newman C; Bailey CD; Ellinas SP; Anderson GG
    Adv Plan Parent; 1975; 10(1):34-8. PubMed ID: 1164986
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaginal and intracervical prostaglandin E2 for cervical ripening: a Doppler study of hemodynamic effects.
    Polvi HJ; Pirhonen JP; Erkkola RU
    Am J Perinatol; 1994 Sep; 11(5):337-9. PubMed ID: 7993512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of pre-induction vaginal prostaglandin E2 gel on subsequent labour.
    Basu SB; Feeney JG
    Ir Med J; 1980 May; 73(5):194-6. PubMed ID: 7390749
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous infusion of prostaglandin E2 for management of premature rupture of membranes.
    Thiery M; Parewijck W; Martens G
    Z Geburtshilfe Perinatol; 1982; 186(2):87-8. PubMed ID: 7202303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.